Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actinic cheilitis
|
8 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Adult Classical Hodgkin Lymphoma
|
10 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Allergic Conjunctivitis
|
2 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Allergic Reaction
|
1019 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||
Allergic rhinitis (disorder)
|
176 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.070 | 0.714 | 7 | 2011 | 2018 | ||||
ALLERGIC RHINITIS, SUSCEPTIBILITY TO
|
1 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.700 | 0 | |||||||
Arthritis
|
69 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Arthritis, Psoriatic
|
89 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.020 | 1.000 | 2 | 2011 | 2011 | ||||
Asthma
|
1536 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.800 | 1.000 | 13 | 2009 | 2018 | ||||
ASTHMA, SUSCEPTIBILITY TO (finding)
|
3 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.700 | 0 | |||||||
Carcinoma of lung
|
1204 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
CATARACT, ANTERIOR POLAR
|
27 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Childhood asthma
|
317 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Chronic Lymphocytic Leukemia
|
291 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Chronic Obstructive Airway Disease
|
852 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.030 | 0.667 | 3 | 2010 | 2017 | ||||
Classical Hodgkin's Lymphoma
|
20 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Colorectal Carcinoma
|
1962 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Community acquired pneumonia
|
13 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Coronary Artery Disease
|
1577 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Dermatitis, Atopic
|
232 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||
Eczema
|
368 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.030 | 0.667 | 3 | 2011 | 2013 | ||||
Fibrosis, Liver
|
64 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Glioblastoma
|
281 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Glioblastoma Multiforme
|
186 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Glioma
|
353 | 0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 | 0.060 | 1.000 | 6 | 2010 | 2018 |